Literature DB >> 23213099

Achieving the best of both worlds.

Andrew H Ko, David Cella.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23213099     DOI： 10.1200/JCO.2012.46.4891

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Patient-reported outcomes as end points and outcome indicators in solid tumours.

Authors:  Angeles A Secord; Robert L Coleman; Laura J Havrilesky; Amy P Abernethy; Gregory P Samsa; David Cella
Journal:  Nat Rev Clin Oncol       Date:  2015-03-10       Impact factor: 66.675

2.  Cost-effectiveness of folfirinox for first-line treatment of metastatic pancreatic cancer.

Authors:  C L Attard; S Brown; K Alloul; M J Moore
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.